Regis Healthcare names Andrew Kinkade as new CEO

Regis Healthcare appoints Andrew Kinkade as CEO, unveiling new leadership strategy and key remuneration details.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is in focus today after the company announced the appointment of Andrew Kinkade as its new Managing Director and Chief Executive Officer. Kinkade joins Regis with an extensive leadership background in aged care, healthcare and finance.

CEO of a company talking.

Image source: Getty Images

What did Regis Healthcare report?

  • Appointment of Andrew Kinkade as new Managing Director & CEO, commencing 20 July 2026
  • Total fixed remuneration of $900,000 per annum, inclusive of superannuation
  • Short Term Incentive of up to 50% of TFR and Long Term Incentive of up to 100% of TFR, subject to performance
  • Sign-on equity award of $1.6 million in Performance Rights, subject to shareholder approval

What else do investors need to know?

Andrew Kinkade brings more than 20 years of experience across aged care, healthcare, private equity, and investment banking, most recently serving as Managing Director at Bupa Villages & Aged Care. He has been recognised for leading operational and cultural transformation, driving both growth and improved care standards.

Kinkade replaces Dr Linda Mellors, who will complete her notice period in June after leading the company for over six years. The board expressed its appreciation for Dr Mellors' significant contributions and steady leadership throughout her tenure.

What's next for Regis Healthcare?

Kinkade's appointment signals a focus on operational transformation and strengthening Regis's position in Australia's aged care sector. The Board noted his track record of leading growth in regulated, people-focused businesses, which aligns with Regis Healthcare's strategic objectives.

Shareholders will vote on key elements of Kinkade's remuneration package, including his sign-on equity award, at the upcoming Annual General Meeting. The company expects a smooth transition and ongoing delivery on its growth plans.

Regis Healthcare share price snapshot

Over the past 12 months, Regis Healthcare shares have declined 2%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 8% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

Surgeon looking at a monitor in an operating room.
Healthcare Shares

The bull and bear case for CSL shares

What are the realistic prospects for this once powerful healthcare company?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Why this red-hot ASX healthcare share keeps climbing

A 1,600% gain hasn't slowed this stock down.

Read more »

A woman smiles at the outlook she sees through binoculars.
Healthcare Shares

How much could the CSL share price rise in the next year?

Can this business deliver very healthy gains from here?

Read more »

Group of scientists cheering in the lab after the company received good news.
Healthcare Shares

Why is this ASX biotech stock blasting higher today?

Investors are backing the biotech's growing commercial and pipeline potential.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

Down 30%, should I buy ResMed shares now?

A sharp fall can make investors cautious, but it can also create opportunity when the long-term business remains strong.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 beaten-down ASX healthcare shares tipped to rise up to 202%

Analysts have a strong buy rating on two of these healthcare stocks, and all three are tipped to have an…

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Share Market News

Investors are buying CSL shares again. Should you?

Some experts believe that 2026 could mark the low point for the biotech company.

Read more »

A group of young people celebrate and party outside.
Healthcare Shares

If I'd invested $5,000 in 4DMedical shares 12 months ago, guess how much I'd have now!

Can the company's share price keep accelerating even higher? Here's what analysts tip for the next 12 months.

Read more »